Sno.
|
Test Name
|
Amount
|
Min Qty
|
Ref. Value
|
1
|
P-ANCA |
1000 |
1 ml
|
|
2 |
Paecilomyces variotii(m24) - SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
3
|
PAEDIATRIC PANEL |
4000 |
2 ml
|
0.00 - 0.34 IU/ml: NOT PRESENT 0.35 - 0.69 IU/ml: LOW THRESHOLD 0.70 - 3.49 IU/ml: SLIGHT INCREASE 3.50 - 17.49 IU/ml: SIGNIFICANTLY INCREASED 17.5 - 49.9 IU/ml: HIGH 50.0 - 100.0 IU/ml: VERY HIGH > 100.0 IU/ml : EXTREMELY HIGH
|
4 |
PAN FUNGI by RT PCR |
4000 |
|
|
5
|
PAP CREATININE |
375 |
|
Adult: Female : 0.51 - 0.95 mg/dl Male : 0.67 - 1.17 mg/dl
|
6 |
PAP SMEAR
|
300 |
|
|
7
|
PAP SMEAR ( 2 - 3 )
|
400 |
|
|
8 |
PAPP - A |
750 |
|
|
9
|
Paracetamol ( c 20)- SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
10 |
PARATHYROID HORMONE ( PTH) |
900 |
1 ml
|
15.0 - 65.0 pg/ml
|
11
|
Parietal Cell Antibodies |
3500 |
|
|
12 |
PARTIAL THROMBOPLASTIN TIME |
300 |
1 ml
|
25.0 - 32.4 Seconds
|
13
|
PARVOVIRUS B19 ANTOBODY IgG |
2500 |
|
Less than 0.9 : Negative 0.9 - 1.1 : Borderline More than 1.1 : Positive
Parvovirus B19 represents the human pathogen in the family Parvoviridae.It replicates in human cells mainly restricted to pro-erythroid progenitor cells. Important diseases caused by B 19 virus include Fifth disease, Aplastic crises in patients with underlying Hemoglobinopathies and Fetal infection resulting from transplacental inoculation.
Parvovirus causes a biphasic illness in humans: first phase is mainly febrile while the second phase includes rash and arthralgia. For laboratory diagnosis of Parvovirus both acute and convalescent sera should be tested.
Parvovirus IgG antibodies appear 4-7 days after the appearance of IgM antibodies and persist for many years or for life.
|
14 |
PARVOVIRUS B19 ANTOBODY IgM |
2500 |
|
Less than 0.9 : Negative 0.9 - 1.1 : Borderline More than 1.1 : Positive
Parvovirus B19 represents the human pathogen in the family Parvoviridae.It replicates in human cells mainly restricted to pro-erythroid progenitor cells. Important diseases caused by B 19 virus include Fifth disease, Aplastic crises in patients with underlying Hemoglobinopathies and Fetal infection resulting from transplacental inoculation.
Parvovirus causes a biphasic illness in humans: first phase is mainly febrile while the second phase includes rash and arthralgia. For laboratory diagnosis of Parvovirus both acute and convalescent sera should be tested.
Parvovirus IgM antibodies appear 2-3 days after the first appearance of rash i.e. about 12th day after infection and decrease after 30-60 days.
|
15
|
PCP |
200 |
|
|
16 |
PCP - PHENCYCLIDINE(URINE) |
200 |
|
Upto 25.00 ng/ml
|
17
|
PCR FOR MTB - CSF |
1750 |
|
|
18 |
PCR FOR MTB - PERIANAL SKIN |
1750 |
|
|
19
|
PCR BY HERPES SIMPLEX VIRUS 1 & 11 BLOOD)
|
1500 |
|
|
20 |
PCR FOR MTB - URINE |
1750 |
|
|
21
|
PCR FOR MTB - ENDOMETRIUM |
1750 |
|
|
22 |
PCR FOR MTB - LYMPHNODE BIOPSY |
1750 |
|
|
23
|
PCR FOR HLA B27 - by RT PCR |
1500 |
2 ml
|
|
24 |
PCR FOR LEPTOSPIRA - BLOOD
|
1000 |
|
|
25
|
PCR FOR MTB - ASCITIC FLUID |
1750 |
|
|
26 |
PCR FOR MTB - PLEURAL FLUID |
1750 |
|
|
27
|
PCR FOR MTB - SPUTUM |
1750 |
|
|
28 |
PCR FOR MTB - |
1750 |
|
|
29
|
PCR FOR MTB - PUS |
1750 |
|
|
30 |
PCR FOR MTB - BLOOD(TaqMan) |
1750 |
|
|
31
|
PCR FOR MTB - BRONCHIAL WASH |
1750 |
|
|
32 |
PCR FOR MTB - FORMALIN - FIXED TISSUES |
1750 |
|
|
33
|
PCR FOR MTB - SYNOVIAL FLUID |
1750 |
|
|
34 |
PCR FOR MTB- ENT |
1750 |
|
|
35
|
PCV (HAEMATOCRIT) |
50 |
|
Male : 40 - 50 % Female : 36 - 46 % Infants 3 months : 32 - 44 % 3 months to 1 year: 36 - 44 % Children : 37 - 41 %
|
36 |
PDGFR A Gene Mutation |
4000 |
|
|
37
|
PDW |
100 |
|
9.0 - 17.0 fl
|
38 |
Pea ( f 12)- SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
39
|
PEANUT (f 13) - SPECIFIC IgE |
600 |
1 ML
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
40 |
PELVIS AP VIEW
|
300 |
|
|
41
|
PELVIS SCAN
|
600 |
|
|
42 |
PEMPHIGUS EPIDERMAL ANTIBODY - IFA |
2500 |
|
|
43
|
Penicilium Notatum (m1) -- SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
44 |
Penicillin G (c 1) - SPECIFIC IGE |
300 |
1 mL
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
45
|
PEPSINOGEN I(FASTING) |
750 |
1 ML
|
MORE THAN 25.0 microgm/L : NORMAL
LESS THAN 25.0 microgm/L Suggestive of
- ATROPHIC GASTRITIS OF THE CORPUS MUCOSA
- GASTROINTESTINAL ENDOSCOPY
|
46 |
PEPSINOGEN II(FASTING) |
750 |
1 ML
|
PEPSINOGEN I / PEPSINOGEN II RATIO -
MORE THAN 3.0 : NORMAL
LESS THAN 3.0 Suggestive OF - CORPUS ATROPHY - INCREASED RISK OF GASTRIC CANCER
|
47
|
Period of Sexual Abstinence
|
0 |
|
|
48 |
Peripheral smear for MF |
200 |
|
|
49
|
Peripheral smear for MP |
200 |
|
|
50 |
pH |
25 |
|
|
51
|
pH - DIALYSIS FLUID
|
25 |
|
|
52 |
Phencyclidine
|
200 |
|
|
53
|
PHENOBARBITAL |
600 |
0.5 ml
|
Therapeutic Level : 10 - 30 Microgm/ml
|
54 |
PHENYTOIN |
600 |
0.5 ML
|
Therapeutic Level : 10 - 20 Microgm/ml
|
55
|
Phospholipase A2 Receptor Ab(PLA 2R Ab) |
4000 |
0.5 ml
|
LESS THAN 0.7 RATIO: NEGATIVE
0.7 - 1.0 RATIO : BORDERLINE
MORE THAN 1.0 RATIO: POSITIVE
The test is useful for the diagnosis of Primary Membranous Glomerulonephritis (MGN), with a sensitivity of 97.5% and Specificity of 100 %.
|
56 |
PHOSPHOLIPID AB IgG |
600 |
1 ML
|
Less than 12 U/ml:Negative 12 - 18 U/ml :Equivocal More than 18 U/ml:Positive
|
57
|
PHOSPHOLIPID AB IGA |
600 |
1 ML
|
Less than 15 U/ml : NEGATIVE
More than 15 U/ml : POSITIVE
|
58 |
PHOSPHOLIPID AB IGM |
600 |
1 ML
|
Less than 12 U/ml:Negative 12 - 18 U/ml :Equivocal More than 18 U/ml:Positive
|
59
|
PHOSPHOROUS - DIALYSIS FLUID |
150 |
|
|
60 |
PHOSPHOROUS -SERUM |
150 |
0.5 ml
|
Children Male(mg/dl) Female(mg/dl) 1 - 30 Days 3.9 - 6.9 4.3 - 7.7 1 month-12Months3.5 - 6.6 3.7 - 6.5 1 yr - 3 yrs 3.1 - 6.0 3.4 - 6.0 4yrs-6yrs 3.3 - 5.6 3.2 - 5.5 7YRS-9YRS 3.0 - 5.4 3.1 - 5.5 10YRS-12YRS 3.2 - 5.7 3.3 - 5.3 13YRS-15YRS 2.9 - 5.1 2.8 - 4.8 16YRS-18YRS 2.7 - 4.9 2.5 - 4.8
ADULT : 2.5 - 4.5 mg/dl
|
61
|
PHYSICAL EXAMINATION
|
150 |
|
|
62 |
PHYSICAL EXAMINATION
|
150 |
|
|
63
|
Pigeon droppings (e 7) - SPECIFIC - IgE |
600 |
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
64 |
Pineapple(f210) - SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
65
|
PITUTARY FOSA (CONE VIEW SELLA)
|
300 |
|
|
66 |
PLANTIAN - SPECIFIC IGE |
600 |
1 ML
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
67
|
PLATELET COUNT |
200 |
1 ml
|
1.5 - 4.1 Lakhs/cmm
|
68 |
PLEURAL FLUID CULTURE & SENSITIVITY |
750 |
|
|
69
|
PLGF ( Placental Growth Factor) |
3000 |
0.5 lm
|
10.0 - 14.6 Weeks : 28.8 - 122 pg/ml 15.0 - 19.6 Weeks : 66.2 - 289 pg/ml 20.0 - 23.6 Weeks : 119 - 605 pg/ml 24.0 - 28.6 Weeks : 169 - 1117 pg/ml 29.0 - 33.6 Weeks : 114 - 1297 pg/ml 34.0 - 36.6 Weeks : 78 - 984 pg/ml 37.0 - Delivery : 54.4 - 862 pg/ml
|
70 |
PML -RARA Quantitative by RT PCR |
5000 |
|
|
71
|
PMSC (b)
|
0 |
|
|
72 |
PMSC(a)
|
0 |
|
|
73
|
PNEUMOSLIDE -10 |
2500 |
|
|
74 |
PNH DIAGNOSTIC PANEL |
5000 |
2 ml
|
|
75
|
POLLEN GRAINS - SPECIFIC IGE |
600 |
1 ml
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
76 |
Poppy Seed ( f 224)- SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
77
|
POTASSIUM ( K +) |
200 |
0.5 ml
|
Pre mature : 3.0 - 6.0 mmol/L Newborn : 3.7 - 5.9 mmol/L Infant : 4.1 - 5.3 mmol/L Children : 3.7 - 4.7 mmol/L
Adult : 3.5 - 5.1 mmol/L
|
78 |
POTASSIUM ( K +) - DIALYSIS FLUID |
200 |
|
|
79
|
POTASSIUM ( K +)(C.S.F) |
200 |
1 Ml
|
|
80 |
Potato (f35) - SPECIFIC IgE |
600 |
|
Less than 0.35 IU/mL: Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL: Very High Positive
|
81
|
PR3 ( PROTEINASE ) |
750 |
0.5 ml
|
Less Than 1.0 Ratio: Negative
More than or equal to 1.0 Ratio: Positive
|
82 |
Prader Willi Syndrome - PWS by FISH |
6000 |
|
|
83
|
PRAWNS - SPECIFIC IGE |
600 |
1.0 ml
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
84 |
Pre Eclampsia |
5000 |
|
For Sinfleton Pregnancy Weeks of Pregnancy SFlt - 1 PlGF Ratio 10 - 14 555 - 2361 29.4 - 183 5.21 - 57.3 15 - 19 470 - 2785 65.7 - 203 4.32 - 26.9 20 - 23 649 - 2944 125 - 541 2.19 - 14.8 24 - 28 630 - 3890 130 - 1108 1.01 - 16.9 29 - 33 707 - 6688 73.3 - 1108 0.945- 86.4 34 - 36 978 - 9921 62.7 - 972 1.38 - 92.0 37 - Delivery 1671 - 11324 52.3 - 659 3.65 - 138
Ratios above 85 indicate the probable development of pre eclampsia
|
85
|
PREGNANCY GTT (ORAL) |
300 |
|
|
86 |
PREGNANCY TEST |
150 |
|
|
87
|
PREGNANCY TEST BY DILUTIONS |
250 |
|
|
88 |
PRO THROMBIN GENE MUTATION |
5500 |
2 ML
|
|
89
|
PROCALCITONIN (PCT) |
1500 |
|
Normal subjects, Chronic inflammatory processes & autoimmune diseases,Viral infection & Mild to moderate localized bacterial infection : < 0.5
SIRS,multiple myeloma, burns : < 0.5- 2.0
Severe bacterial infections,sepsis, Multiple organ failure : > 2.0 (frequently 10 - 100)
|
90 |
Prog.Motile Sperm(a+b)
|
0 |
|
>=20
|
91
|
PROGESTERONE |
300 |
1 ml
|
Males : <0.05 - 0.149 ng/ml Females Follicular Phase : 0.057 - 0.89 ng/ml Ovulation Phase : 0.121 - 12.0 ng/ml Luteal Phase : 1.83 - 23.9 ng/ml Postmenopausal : < 0.05 - 0.126 ng/ml Pregnant Females 1 st Trimester : 11.0 - 44.3 ng/ml 2 nd Trimester : 25.4 - 83.3 ng/ml 3 rd Trimester : 58.7 - 214 ng/ml
Note: Kindly note the changes in reference interval.
|
92 |
PROLACTIN |
300 |
1 ml
|
FEMALE Adult : 4.79-23.3 ng/ml. Preg 3rd trimester : 95 - 473 ng/ml. MALE Adult : 4.04 -15.2 ng/ml.
Note : Physiological increase in Prolactin levels are seen in Pregnancy, Lactation, Stress, Drug Treatment with Anticonvulsants, Oral Contraceptives,and Antipsychotics,sleep, Depression.
Pathological conditions in which Prolactin is increased include Acromegaly, PCOD, Chronic Hypothyrodism etc.
|
93
|
PROPOXYPHENE(URINE) |
200 |
|
|
94 |
Prostate Biopsy 12 Cores
|
2500 |
|
|
95
|
Prostate Biopsy 6 Cores
|
1500 |
|
|
96 |
PROSTATE NEEDLE BIOPSY
|
1000 |
|
|
97
|
PROTEIN C - Antigen |
2500 |
0.5 ml
|
70 - 140 %
|
98 |
PROTEIN S - Antigen |
4000 |
0.5 ml
|
60 - 150%
|
99
|
PROTEIN (CYSTIC FLUID) |
100 |
|
|
100 |
PROTEIN (DIALYSIS FLUID) |
100 |
|
|
101
|
PROTEIN (SYNOVIAL FLUID) |
100 |
|
|
102 |
PROTEIN / CREATININE RATIO (PCR) |
200 |
|
|
103
|
Protein C - Activity |
3000 |
|
70 % to 130 %
|
104 |
PROTEIN S - Activity |
4000 |
|
Male : 93.5 to 126.5 % Female : 72 to 116 %
|
105
|
Protein S Antigen - Free |
5000 |
1 ml
|
50 - 130 %
|
106 |
PROTEINS (ASCITIC FLUID) |
100 |
|
> 3 gm/dl : Exudate < 3 gm/dl : Transdate
|
107
|
PROTEINS (ASPIRATED FLUID)
|
100 |
|
|
108 |
PROTEINS (BRONCHIAL WASH) |
100 |
|
|
109
|
PROTEINS (CSF) |
100 |
|
Adult : 15 - 45 mg/dl New Born : 15 - 130 mg/dl
|
110 |
PROTEINS (Pericardial Fluid) |
100 |
|
|
111
|
PROTEINS (PERITONEAL FLUID) |
100 |
|
|
112 |
PROTEINS (PLEURAL FLUID) |
100 |
|
> 3 gm/dl : Exudate < 3 gm/dl : Transudate
|
113
|
PROTEINS(URINE) |
50 |
|
|
114 |
PROTHROMBIN TIME |
300 |
1 ml
|
|
115
|
PSA ( PROSTATE SPECIFIC ANTIGEN) |
400 |
0.5 ml
|
Up to 40 Yrs : 1.4 ng/ml 40 - 49 Yrs : 2.0 ng/ml 50 - 59 Yrs : 3.1 ng/ml 60 - 69 Yrs : 4.1 ng/ml Above 70 Yrs : 4.4 ng/ml
PSA levels are increased ( usually upto 10 ng/ml)in Benign Enlargement of Prostate, after Rectal examination, or severe constipation.
Higth levels ( 10 to 25 ng/ml) are indicative of Prostate Carcinoma, and should be used along with other Clinical data to confirm Diagnosis. Combining Total PSa with Free PSA will increase Diagnostic Sensitivity and specificity and also indicate the need for Biopsy.
Very High levels ( > 500 ng/ml) are found in Bone Metastatis .
|
116 |
PT-INR Stago |
150 |
1 ml
|
Reference Range for INR:
Normal : 0.9 to 1.1 Therapeutic Levels Myocardial Infraction : 2.0 to 3.0 Deep Vein Thrombosis : 2.0 to 3.0 Pulmonary Embolism : 2.0 to 3.0 Artificail Cardiac Valve : 3.0 to 4.5 Recur.Systemic Embolism : 3.0 to 4.5
|
117
|
PULMONARY FUNCTION TEST(SPIROMETRY)
|
300 |
|
|
118 |
PUS CULTURE & SENSITIVITY
|
400 |
|
|
119
|
PUS FOR AFB STAIN |
250 |
|
|
120 |
PUS FOR GRAM STAIN
|
200 |
|
|
121
|
Pyruvate |
1800 |
|
0.3 - 0.9 mg/dl
|
122 |
Pyruvate - CSF |
1800 |
|
0.06 - 0.19 mmol/L
|